Profile picture

Mr Amol Dhamane

Bristol-Myers Squibb, Lawrenceville (United States of America)
Follow
Logo ESC

Contributor content

Anticoagulant treatment patterns and thromboembolic events by tumor type among patients with VTE and cancer
Presentation
Anticoagulant treatment patterns and thromboembolic events by tumor type among patients with VTE and cancer
Read more
Effectiveness, safety, and composite clinical outcomes between apixaban and other oral anticoagulants for non-valvular atrial fibrillation patients in the US Medicare population
Presentation
Effectiveness, safety, and composite clinical outcomes between apixaban and other oral anticoagulants for non-valvular atrial fibrillation patients in the US Medicare population
Read more
Effectiveness, safety, and composite clinical outcomes of apixaban, dabigatran, rivaroxaban, relative to warfarin in non-valvular atrial fibrillation patients in the US Medicare population
Presentation
Effectiveness, safety, and composite clinical outcomes of apixaban, dabigatran, rivaroxaban, relative to warfarin in non-valvular atrial fibrillation patients in the US Medicare population
Read more

ESC 365 is supported by

novartis Explore sponsored resources